Cincinnati Children's Hospital Medical Center (CCHMC) is one of the largest comprehensive pediatric medical centers in the United States and a recognized leader in clinical care, research, and training relative to the health and diseases of infants and children. CCHMC provides inpatient hospital care and outpatient subspecialty services for virtually all newborns, infants, and children residing in the greater Cincinnati region. In 2009, CCHMC announced the establishment of the CCHMC Perinatal Institute with the mission to improve the health of all newborn infants through innovation in science, clinical care, education, training and community outreach. The Perinatal Institute builds upon a 20-year evolution and integration of research and clinical programs within the Division of Neonatology and Pulmonary Biology. The Division of Neonatology has maintained membership in the Eunice Kennedy Schriver NICHD Neonatal Research Network (NRN) for 20 years. Over that time clinical investigators in the Division have established a record of clinical research productivity based on: 1) consistently high levels of enrollment;2) consistently high levels of follow-up;and 3) a past record of thought leadership. CCHMC is also well positioned for future intellectual contribution to the NRN. CCHMC and University of Cincinnati (UC) have been granted a CTSA award which provides resources to enable community-wide and multicenter translational research at all levels. Incorporation of accurate phenotyping and specimen accrual into Network studies will facilitate translation of basic discoveries to human applications. Faculty and institutional strengths at CCHMC will add value to NRN studies by engagement of basic and translational science. Examples include: 1) Pulmonary Biology - discovery of genetic programs regulating lung development led by Dr. Jeff Whitsett;2) Perinatal Biology - understanding the influence of fetal inflammation on pulmonary outcome led by Dr. Alan Jobe;and 3) Human Milk Sciences - investigating the importance of bioactive substance in milk led by Dr. Ardythe Morrow. This cutting-edge research will inform the use of genomics and other high throughput technologies to understand the molecular underpinning of neonatal diseases and identify targets for their prevention and treatment.

Public Health Relevance

The charge of the NICHD NRN is to conduct large clinical studies to evaluate and improve preventative, diagnostic and therapeutic strategies for the care of newborn infants. We propose to test the hypothesis that judicious early empirical antibiotic use among preterm infants will improve their survival without NEC. The concept incorporates mechanistic studies and quality improvement methods for study implementation.

National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
Application #
Study Section
Special Emphasis Panel (ZHD1-DSR-A (03))
Program Officer
Raju, Tonse N
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Cincinnati Children's Hospital Medical Center
United States
Zip Code
Ambalavanan, Namasivayam; Cotten, C Michael; Page, Grier P et al. (2015) Integrated genomic analyses in bronchopulmonary dysplasia. J Pediatr 166:531-7.e13
Fernandez, Erika; Watterberg, Kristi L; Faix, Roger G et al. (2014) Incidence, management, and outcomes of cardiovascular insufficiency in critically ill term and late preterm newborn infants. Am J Perinatol 31:947-56
Wadhawan, R; Oh, W; Hintz, S R et al. (2014) Neurodevelopmental outcomes of extremely low birth weight infants with spontaneous intestinal perforation or surgical necrotizing enterocolitis. J Perinatol 34:64-70
Hartnett, M Elizabeth; Morrison, Margaux A; Smith, Silvia et al. (2014) Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants. Invest Ophthalmol Vis Sci 55:6194-203
DeMauro, Sara B; D'Agostino, Jo Ann; Bann, Carla et al. (2014) Developmental outcomes of very preterm infants with tracheostomies. J Pediatr 164:1303-10.e2
Stark, Ann R; Carlo, Waldemar A; Vohr, Betty R et al. (2014) Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants. J Pediatr 164:34-39.e2
Davis, A S; Hintz, S R; Goldstein, R F et al. (2014) Outcomes of extremely preterm infants following severe intracranial hemorrhage. J Perinatol 34:203-8
Shankaran, Seetha; Laptook, Abbot R; Pappas, Athina et al. (2014) Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial. JAMA 312:2629-39
Stevens, Timothy P; Finer, Neil N; Carlo, Waldemar A et al. (2014) Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). J Pediatr 165:240-249.e4
Pappas, Athina; Kendrick, Douglas E; Shankaran, Seetha et al. (2014) Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr 168:137-47

Showing the most recent 10 out of 149 publications